Organon & Co.
OGN· NYSE
Filed Mar 21, 2022 · 10-K · 80 days after period end · 0001821825-22-000002
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|
| Revenue | $1.60B | $1.61B |
| Net Income | $202.00M | $368.00M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 21, 2022 · 80 d after period end